Back to Search Start Over

Number of botulinum toxin injections needed to stop requests for treatment for chronic lateral epicondylar tendinopathy. A 1-year follow-up study

Authors :
Cogne, Melanie
Creuze, A.
Petit, H.
Delleci, C.
Dehail, Patrick
de Seze, Mathieu
CHU Bordeaux [Bordeaux]
Handicap Activité Cognition Santé [Bordeaux] (HACS)
Université de Bordeaux (UB)-Institut National de Recherche en Informatique et en Automatique (Inria)-CHU Bordeaux [Bordeaux]-Institut National de la Santé et de la Recherche Médicale (INSERM)
CHU Pontchaillou [Rennes]
CCSD, Accord Elsevier
Source :
Annals of Physical and Rehabilitation Medicine, Annals of Physical and Rehabilitation Medicine, Elsevier Masson, 2019, 62 (5), pp.336-341. ⟨10.1016/j.rehab.2018.12.003⟩
Publication Year :
2019
Publisher :
HAL CCSD, 2019.

Abstract

International audience; BACKGROUND: Epicondylar tendinopathy ("tennis elbow") is a serious issue in manual labourers. Symptoms can persist over months or even more than 1 year, even when treated with trinitrine patches, acupuncture, sclerosis of neovessels, shock-wave therapy, autologous blood injections, platelet-rich plasma or hyaluronic acid. Botulinum toxin (BoNT-A) injections showed promising short-term results, but the long-term beneficial effects are not yet known. OBJECTIVE: We aimed to assess the long-term effect, side effects and recurrence rate after BoNT-A injections on chronic lateral epicondylar tendinopathy during 1 year. METHODS: This open study followed a 3-month randomized controlled trial. We included 50 patients followed at day 0 (V0), 90 (V1), 180-270 (V2) and 365 (V3). The main judgment criterion was the number of BoNT-A injections required to achieve pain relief with no further request for treatment by the patient. RESULTS: After one BoNT-A injection, 22/50 (44%) patients did not ask for further treatment during follow-up because of complete pain relief, and 20/50 (40%) asked for a second BoNT-A injection. For 20 patients with a second injection, 18 (90%) did not ask for further treatment during follow-up. Only 1 patient had a recurrence of pain after an initial pain relief of greater than 75%. Quality of life, and painful and maximal gripping force improved significantly at V1, V2 and V3 as compared with V0, and repercussions on daily and professional activities decreased significantly (P

Details

Language :
English
ISSN :
18770657
Database :
OpenAIRE
Journal :
Annals of Physical and Rehabilitation Medicine, Annals of Physical and Rehabilitation Medicine, Elsevier Masson, 2019, 62 (5), pp.336-341. ⟨10.1016/j.rehab.2018.12.003⟩
Accession number :
edsair.od......1398..ea83d8cd26ff4935b3d841a7462914e2
Full Text :
https://doi.org/10.1016/j.rehab.2018.12.003⟩